Impetigo in French Guyana. A prospective clinical, bacteriological, toxinological and antibiotics succeptibility study;L'impetigo en Guyane Francaise: Etudes clinique, bacteriologique, toxinologique et de sensibilite aux antibiotiques

Annales de Dermatologie et de Venereologie

Volumn 125, Issue 10, 1998, Pages 688-693

  Couppie P ^a,d   Sainte Marie, D ^a   Prevost G ^b   Gravet, A ^b   Clyti, E ^a   Moreau, B ^c   Monteil, H ^b   Pradinaud, R ^a  

^a Centre Hospitalier de Cayenne

^b Institut de Bacteriologie   (France)

^c Lab du Ctr Hospitalier de Cayenne

^d Service de Dermatologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; FUSIDIC ACID; JOSAMYCIN; OXACILLIN; ROXITHROMYCIN; ANTIINFECTIVE AGENT; CHLORTETRACYCLINE; PENICILLIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL SKIN DISEASE; BACTERIAL VIRULENCE; CLINICAL ARTICLE; FRENCH GUIANA; HUMAN; IMPETIGO; INCIDENCE; STAPHYLOCOCCUS INFECTION; ADOLESCENT; CHILD; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; MALE; PROSPECTIVE STUDY;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHLORTETRACYCLINE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FUSIDIC ACID; HUMANS; IMPETIGO; JOSAMYCIN; MALE; OXACILLIN; PENICILLINS; PROSPECTIVE STUDIES; ROXITHROMYCIN;

EID: 0032186429     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Maleville J, Taieb A, Massicot P. Affections bactériennes communes. In : Saurat JH, Grosshans E, Laugier P, Lachapelle JM. (Eds) Dermatologie et Vénéréologie. Masson 1986:106-10.
2. Comité de l'Antibiogramme de la Société Française de Microbiologie. Communiqué 1996 (En encart). Path Biol 1996;44,no8,I-VIII.
3. Caverelli J, Prévost G, Bourguet W, Moulinier L, Chevrier B, Delagoute B, et al. The structure of Staphylococcus aureus epidermolytic toxin A, an atypic serine protease, at 1.7 a resolution. Structure 1997;5:813-24.
4. Finck-Barbancon V, Prévost G, Piémont Y. Improved purification of leukocidin from Straphylococcus aureus and toxin distribution among hospital strains. Res Microbiol 1991;142:75-85.
5. Sabouraud R. In: Pyodermites et eczémas. Ed Masson: Paris 1928:99-120.
6. Noble WC, White MI. Staphylococcal skin infection in man. In: Easmon CSF, Adlam C. (Eds). Straphylococci and Staphylococcal infection. Academic Press London, 1983:165-91.
7. nd edit. Blackwell Scientific Publications, London, 1972:482-5.
8. th edit. Oxford. Blackwell Scientific Publications 1992:953-1031.
9. Braun-Falco O, Plewig G, Wolff HH, Winkelmann RK. In: Dermatology. Springer-Verlag. Berlin, 1991:154-84.
10. Shriner DL, Schwartz RA, Janniger CK. Impétigo. Cutis 1995;56:30-2.
11. Dajani AS, Ferrieri P, Wannamaker LW. Natural history of impetigo. II. Etiologic agents and bacterial interactions. J Clin Invest 1972;51:2863-71.
12. Ferrieri P, Dajani AS, Wannamaker LW, Chapman SS. Natural history of impetigo. I. Site sequence of acquisition and familial patterns of spread of cutaneous streptococci. J Clin Invest 1972;51:2851-62.
13. Hall WD, Blumberg RW, Moddy MD. Studies in children with impetigo. Bacteriology, serology and incidence of glomerulonephritis. Am J Dis Child 1973;125:800-6.
14. Connor BL. Impetigo contagiosa in the United Kingdom. Br J Dermatol 1972;86 (suppl. 8):48-54.
15. Maleville J, Capbern M, Boineau D, Marc-Antoine H, Mollard S, Renesson-Philippon D. La flore microbienne cutanée chez 206 enfants atteints de dermite fessière et de pyodermites. Ann Dermatol Venereol 1977;104:701-5.
16. Coskey RJ, Coskey LA. Diagnosis and treatment of impetigo. J Am Acad Dermatol 1987;17:62-3.
17. Melish ME, Glascow LA. The staphylococcal scalded-skin syndrome. Development of an experimental model. N Engl J Med 1970;282:1114-9.
18. Elias PM, Levy SW. Bullous impetigo. Occurrence of localized scalded skin syndrome in an adult. Arch Dermatol 1976;112:856-8.
19. Baker DH, Dimond RL, Wuepper KD. The epidermolytic toxin of Staphylococcus aureus: its failure to bind to cells and its detection in blister fluids of patients with bullous impetigo. J Invest Dermatol 1978;71:274-5.
20. Piemont Y, Rifai S, Monteil H. Les exfoliatines de Staphylocaccus aureus. Bull Inst Pasteur 1988;86:263-96.
21. De Azevedo J, Arbuthnott JP. Prevalence of epidermolytic toxin in clinical isolates of Staphylococcus aureus. J Med Microbiol 1981;14:341-4.
22. Piemont Y, Rasoamananjara D, Fouace JM, Bruce T. Epidemiological investigation of exfoliatin toxin-producing Staphylococcus aureus strains in hospitalized patients. J Clin Microbiol 1984;19:417-20.
23. Misko ML, Terracina JR, Diven DG. The frequency of erythromycin-resistant Staphylococcus aureus in impetiginized dermatoses. Pediatr Dermatol 1995;12:12-5.